BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.300
+0.020 (1.56%)
At close: Nov 7, 2025, 4:00 PM EST
1.357
+0.056 (4.35%)
After-hours: Nov 7, 2025, 7:26 PM EST
BioCardia Market Cap
BioCardia has a market cap or net worth of $13.79 million as of November 7, 2025. Its market cap has increased by 58.80% in one year.
Market Cap
13.79M
Enterprise Value
13.56M
1-Year Change
58.80%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $13.79M, a decrease of -52.56%. That is a compound annual growth rate of -7.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 13.79M | 38.00% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | 49.20M | 95.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 251.76B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |